METTL14 rs3087958: Understanding Your Genetic Variant
The rs3087958 variant is a single-nucleotide polymorphism located within the METTL14 gene. Recent research suggests this variant may be associated with breast cancer susceptibility, though these findings are primarily observed in specific populations.
What each genotype means
Baseline breast cancer risk
This genotype represents the baseline state for this variant in the METTL14 gene. Research suggests that individuals with this genotype do not carry the specific protective association linked to the G allele, though overall breast cancer risk is influenced by many genetic and environmental factors.
The frequency of this genotype varies significantly by ancestry, with the A allele being common in many global populations.
Reduced breast cancer risk
Carrying one copy of the G allele is associated with a protective effect against breast cancer risk. This suggests a potential reduction in susceptibility compared to those without the G allele, though this should be viewed as one small factor within a complex genetic landscape.
This heterozygous genotype is found at varying frequencies across different global populations, reflecting the distribution of the G allele.
Reduced breast cancer risk
Carrying two copies of the G allele is associated with a protective effect against breast cancer risk. While this genotype is linked to a lower statistical risk, it does not eliminate the possibility of developing breast cancer, and individuals should continue to follow standard screening guidelines.
This homozygous genotype is less common than the heterozygous state in many populations, with prevalence highly dependent on ancestral background.
What is rs3087958?
A single-nucleotide polymorphism (SNP) is a variation at a single position in a DNA sequence among individuals. The variant rs3087958 represents a specific change where the nucleotide base is either an adenine (A) or a guanine (G). This SNP is situated within the METTL14 gene, which provides instructions for making a protein involved in complex cellular processes. Scientists study these variations to understand how subtle differences in our genetic code might influence health outcomes or disease susceptibility. Because rs3087958 is located in a region of the genome that regulates gene expression, researchers investigate whether the presence of different alleles—A or G—alters the function of the METTL14 protein or the amount of protein produced by the cell. Understanding the location and nature of this SNP is the first step in determining its potential biological impact on human health.
The Role of the METTL14 Gene
The METTL14 gene encodes a protein that acts as a methyltransferase. This protein is a critical component of a larger complex responsible for N6-methyladenosine (m6A) modification, which is the most prevalent internal modification found in messenger RNA (mRNA) in eukaryotes. By installing these chemical marks on RNA molecules, the METTL14 complex helps regulate essential cellular functions, including mRNA splicing, stability, and translation. Essentially, it acts as a regulatory valve for gene expression, ensuring that cells produce the right proteins at the right time. Because this process is fundamental to cell growth and differentiation, disruptions or variations in the METTL14 gene can have downstream effects on how cells behave. Research into METTL14 is ongoing, as scientists continue to uncover how its role in m6A modification influences various biological pathways, including those involved in cancer development and neurodegenerative conditions.
Research and Evidence Strength
The association between rs3087958 and health outcomes is currently considered to have moderate evidence strength. Recent case-control studies, such as those published in Clinical Breast Cancer, have explored the relationship between METTL14 polymorphisms and breast cancer susceptibility. These studies have suggested that the A>G variant may be linked to differences in breast cancer risk, particularly when interacting with various reproductive factors. However, it is important to note that these findings are often specific to certain ethnic groups, such as Chinese women, and may not be generalizable to all populations. Genetic associations can be complex, and the influence of a single SNP is rarely the sole cause of a disease. Further large-scale, multi-ethnic studies are required to confirm these associations and to fully understand the biological mechanisms by which this variant might influence cancer risk. As with all genetic research, these findings represent statistical correlations rather than direct causation.
Population Frequency
The frequency of the rs3087958 variant is known to be variable across different global populations. Genetic databases like gnomAD provide data on how common specific alleles are in various ancestral groups, which is essential for understanding the context of any genetic association. Because allele frequencies can differ significantly between populations, a variant that appears to have an effect in one group may not show the same pattern in another. Researchers use this frequency data to ensure that genetic studies are robust and to avoid drawing conclusions that are not applicable to the broader human population. If you are interested in the specific frequency of this variant in your own ancestral background, resources like the Genome Aggregation Database (gnomAD) offer detailed, publicly available information on global allele distributions.
Interpreting Your Genetic Information
It is important to remember that genetic variants like rs3087958 are only one piece of a much larger puzzle. Health outcomes are influenced by a complex interplay of genetics, environment, lifestyle, and chance. Having a specific genotype does not mean you will or will not develop a particular condition. This information is intended for educational purposes and should not be used for medical diagnosis or to make personal health decisions. If you have concerns about your health or your risk for specific diseases, the most appropriate step is to consult with a qualified healthcare professional or a genetic counselor. They can help you interpret your genetic information in the context of your personal and family medical history. Never use genetic data to change your medical care or treatment plans without first discussing it with your doctor or a licensed medical provider.
How common is this variant?
The frequency of the rs3087958 variant is variable across different global populations, and users should consult gnomAD for ancestry-specific data.
Frequently asked questions
Does having the AG or GG genotype mean I am protected from breast cancer?
No. While some studies suggest a statistical association between these genotypes and a reduced risk of breast cancer, this does not guarantee protection. Breast cancer risk is influenced by many factors, including genetics, lifestyle, and environment.
Should I get tested for rs3087958?
There is no clinical recommendation to test for this specific variant. Genetic testing for common variants should be discussed with a healthcare provider to determine if it is relevant to your personal health goals.
Where can I find more information about METTL14?
You can find reliable information about the METTL14 gene and its functions on resources like GeneCards or the National Center for Biotechnology Information (NCBI) website.
Are these findings applicable to everyone?
Not necessarily. Many genetic studies are conducted on specific populations, and the results may not be the same for people of different ancestral backgrounds. Always consider the population context of any genetic research.
Sources & further reading
Educational information only, last refreshed 9/18/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs3087958?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29